Pursuant to provisions of Regulation 18(i) of the Buy-back Regulations, Jenburkt Pharmaceuticals has submitted the daily report with respect to Equity Shares bought back by the Company on 12th January, 2023. The details will also be made available on the website of the Company: www.jenburkt.com.
The above information is a part of company’s filings submitted to BSE.